Philippe Erbs
17Patents
4h-index
8Co-inventors
49Inventor score
Filing activity: Aug 14, 2000 → Apr 10, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8778328B2 | Poxviral oncolytic vectors | Chemistry; Metallurgy | 17 | Active |
| US9180150B2 | Poxviral oncolytic vectors | Chemistry; Metallurgy | 16 | Active |
| US6596533B1 | Mutant having uracil phosphoribosyl transferase activity | Chemistry; Metallurgy | 13 | Expired |
| US7572438B2 | Mutant having uracil phosphoribosyl transferase activity | Chemistry; Metallurgy | 7 | Expired |
| US7049117B2 | Mutant possessing uracil phosphoribosyl transferase activity | Chemistry; Metallurgy | 3 | Expired |
| US7790445B2 | Polypeptide having an improved cytosine deaminase activity | Human Necessities | 2 | Expired |
| US9687515B2 | Poxviral oncolytic vectors | Chemistry; Metallurgy | 2 | Active |
| US9024003B2 | Avian telomerase reverse transcriptase | Chemistry; Metallurgy | 0 | Active |
| US9884080B2 | Poxviral oncolytic vectors | Chemistry; Metallurgy | 0 | Active |
| US8357531B2 | Immortalized avian cell lines | Chemistry; Metallurgy | 0 | Active |
| US8211421B2 | Mutant having uracil phosphoribosyl transferase activity | Chemistry; Metallurgy | 0 | Active |
| US8470591B2 | Kit of parts designed for implementing an antitumoral or antiviral treatment in a mammal | Human Necessities | 0 | Active |
| US8257692B2 | Polypeptide having an improved cytosine deaminase activity | Human Necessities | 0 | Active |
| US8361788B2 | Immortalized avian cell lines comprising E1A nucleic acid sequences | Chemistry; Metallurgy | 0 | Active |
| US8513018B2 | Immortalized avian cell lines | Chemistry; Metallurgy | 0 | Active |
| US8226954B2 | Polypeptide having an improved cytosine deaminase activity | Human Necessities | 0 | Active |
| US7348014B2 | Poxvirus with targeted infection specificity | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.